Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

ConclusionsHemophilia A with high-titer inhibitors is a disease that generates significant pressure on the Colombian health system, mainly linked to the cost of factors and bypassing agents.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research